Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

SHARE-BASED COMPENSATION

v3.22.2.2
SHARE-BASED COMPENSATION
9 Months Ended
Sep. 30, 2022
Share-Based Compensation [Abstract]  
SHARE-BASED COMPENSATION

9.SHARE-BASED COMPENSATION

The Company’s share-based compensation plans includes stock options and Restricted Share Units (“RSU”). The Company has reserved up to 15% of the issued and outstanding Common Shares for the granting of stock options and RSUs to eligible Employees, Officers, Directors and external consultants.

Common shares outstanding, September 30, 2022

111,890,707

Common shares reserved for issuance: 15%

16,783,606

Stock options outstanding, September 30, 2022

(7,426,665

)

RSU outstanding, September 30, 2022

(5,499,663

)

Common shares reserved for future grants

3,857,278

(a) Stock Options

The Company granted stock options to acquire common stock through our stock option plan of which the following are outstanding as September 30:

2022

2021

Stock

Options

Weighted

Average

Exercise

Price

Stock

Options

Weighted

Average

Exercise

Price

$

$

Balance, January 1

5,257,089

1.73

2,923,770

1.76

Granted

4,755,758

0.57

3,316,195

1.99

Forfeited

(2,242,337

)

1.82

(19,568

)

0.73

Expired

(343,845

)

1.59

(84,974

)

3.58

Exercised

--

--

(352,133

)

1.71

Balance, September 30

7,426,665

0.94

5,783,290

1.87

(b)Restricted Share Units

The Company granted RSUs to Officers and Directors through our incentive share award plan. Grants of RSUs to Directors vest either immediately or on the date of the next Annual General Meeting. Grants of RSUs to employees vest over a four-year period. The following RSUs are outstanding at September 30:

2022

2021

Balance at Jan 1

1,581,607

--

Granted

4,758,389

2,253,040

Exercised

(702,000

)

--

Cancelled

(132,083

)

--

Expired

(6,250

)

Balance, September 30

5,499,663

2,253,040

(c)Stock-Based Compensation

The following table shows the stock-based compensation expense.

Three Months Ended

Nine Months Ended

Sept 30, 2022

Sept 30, 2021

Sept 30, 2022

Sept 30, 2021

$

$

$

$

Stock options

278

706

233

1,661

RSUs

637

595

1,226

1,591

Total G&A - Stock options & RSUs

915

1,301

1,459

3,252

Stock options

243

121

587

368

RSUs

88

-

88

-

Total R&D - Stock options & RSUs

331

121

675

368

Share-based compensation expense

1,246

1,422

2,134

3,620